Skip to content

Venture

LOGO 6-01

Affiliations

Columbia University

Technologies

Therapeutic

Indication

Basic Research

Central Nervous System Disorders

Pain Management

I am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression.

Kures, Inc. Team:

Andrew Kruegel